China Biobank Market Size & Outlook, 2023-2030
China biobank market, 2018-2030 (US$M)
Related Markets
China biobank market highlights
- The China biobank market generated a revenue of USD 5,765.0 million in 2023 and is expected to reach USD 11,288.9 million by 2030.
- The China market is expected to grow at a CAGR of 10.1% from 2024 to 2030.
- In terms of segment, biobanking equipment was the largest revenue generating product in 2023.
- LIMS is the most lucrative product segment registering the fastest growth during the forecast period.
Biobank market data book summary
| Market revenue in 2023 | USD 5,765.0 million |
| Market revenue in 2030 | USD 11,288.9 million |
| Growth rate | 10.1% (CAGR from 2023 to 2030) |
| Largest segment | Biobanking equipment |
| Fastest growing segment | LIMS |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Biobanking Equipment, Biobanking Consumables, LIMS |
| Key market players worldwide | Thermo Fisher Scientific Inc, Merck KGaA, Qiagen NV, Booz Allen Hamilton Holding Corp Class A, Tecan Group AG, Danaher Corp, Becton Dickinson & Co, Taylor-Wharton, Charles River Laboratories International Inc, Lonza Group Ltd, STEMCELL Technologies, PromoCell GmbH |
Other key industry trends
- In terms of revenue, China accounted for 7.5% of the global biobank market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China biobank market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 2,169.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Biobank Market Scope
Biobank Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
China biobank market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biobank market will help companies and investors design strategic landscapes.
Biobanking equipment was the largest segment with a revenue share of 77.25% in 2023. Horizon Databook has segmented the China biobank market based on biobanking equipment, biobanking consumables, lims covering the revenue growth of each sub-segment from 2018 to 2030.
High investment in biomedical research globally has led to the need for large number of high-quality bio specimens. Largest population and abundant clinical resources are factors that contribute to the growth of biobanks market in China.
Disease-oriented biobanks are established to support translational medicine programs, e.g., Immortalized Cell Bank of Different Chinese Ethnic Groups (1994) and the Bank of Chinese Genetic Resources (2003).
Population-based biobanks help identify patterns associated with various genetic diseases, such as autism, and help realize personalized & precision medicines. The majority of funds to establish and operate disease-oriented biobanks are received from government bodies and project funds apart from self-funding.
Reasons to subscribe to China biobank market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of China biobank market databook
-
Our clientele includes a mix of biobank market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China biobank market , including forecasts for subscribers. This country databook contains high-level insights into China biobank market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
China biobank market size, by product, 2018-2030 (US$M)
China Biobank Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
